[WFNMB]Poster

The13th Congress of the World Federation of Nuclear Medicine and Biology(WFNMB2022) » [WFNMB]Poster Program

Radiopharmacy1

Technology

Sun. Sep 11, 2022 8:00 AM - 8:00 PM Web distribution only (配信のみ)

+Add all to schedule

[WP-31-1] Making errors in Lu-177-Dota-(Tyr3)-Octreotate synthesis – still within QC specifications or not?

Katrimari Kiviluoto^1,2、Vappu Reijonen¹、Veera Ahtiainen¹ (1.Molecular Radiotherapy Unit, Helsinki University Hospital Comprehensive Cancer Center、2.HUS Pharmacy, Helsinki University Hospital)

[WP-31-2] Automated radiosynthesis of ¹⁸F-fluoromethylated tracers using the simplified one-pot ¹⁸F-fluoromethylation via [¹⁸F]fluoromethyl tosylate.

Kazunori Kawamura¹、Wakana Mori¹、Masayuki Fujinaga¹、Yusuke Kurihara^1,2、Masanao Ogawa^1,2、Kaito Tsukagoe^1,2、Takayuki Ohkubo^1,2、Hiroki Hashimoto¹、Nobuki Nengaki^1,2、Ming-Rong Zhang¹ (1.National Institutes for Quantum Science and Technology、2.SHI Accelerator Service Ltd.)

[WP-31-3] Electrochemical handling of ultra-trace radioactive copper for highly efficient separation and reagent preparation

Masanobu Mori¹、Yumi Sugo²、Shin-Ichi Ohira³、Hinako Manabe¹、Syohei Obata³、Ryoma Miyachi³、Kei Toda³、Noriko Ishioka² (1.Graduate School of Science and Technology, Kochi University、2.Department of Radiation-Applied Biology Research, Takasaki Advanced Radiation Research Institute, National Institutes for Quantum Science and Technology、3.Department of Chemistry, Kumamoto University)

[WP-31-4] Development of novel [¹⁸F] FBPA synthesis method from pinacol boran precursor and [¹⁸F] fluoride ion using an automatic synthesizer.

Yasukazu Kanai¹、Toshimitsu Watanabe²、Youichiro Ohta^3,4、Yoshihide Hattori³、Kouki Uehara⁴、Sadahiro Naka⁶、Toshihiro Sakai⁵、Naoya Kondo¹、Takashi Temma¹、Mitsunori Kirihata³ (1.Osaka Medical And Pharmaceutical University、2.Sumitomo Heavy Industry, LTD.、3.Osaka Metropolitan University、4.STELLA PHARMA CORPORATION、5.Hanwa Intelligent Medical Center、6.Osaka University Graduate School of Medicine)

[WP-31-5] Optimizing of automated synthesis of 68Ga-DOTATOC with Ga-68 produced by cyclotron liquid target system for clinical use

Yoichi Shimizu¹、Keizo Kobayashi³、Mitsushige Kumano³、Akihiko Okamura³、Tsuneo Saga²、Yuji Nakamoto^1,2 (1.Department of Radiology, Kyoto University Hospital、2.Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University、3.NMP business support company, Limited)

[WP-31-6] Automated production of [¹⁸F]MK-6240 on AllinOne

Tetsuya Mori、Akira Makino、Yasushi Kiyono、Hidehiko Okazawa (University of Fukui)

[WP-31-7] Development of high-yield and clinical grade cyclotron based 68Ga-PSMA-11 production system

Satoshi Ueno¹、Kanako Some²、Takashi Oda¹、Francisco Guerra²、Kazuhiro Takahashi³、Ken-ichi Nishijima³、Hiroki Higuchi²、Tohru Shiga³、Yuji Kuge⁴ (1.Sumitomo Heavy Industries, Ltd.、2.Sumitomo Heavy Industries, Ltd.、3.Advanced Clinical Research Center, Fukushima Medical University、4.Central Institute of Isotope Science, Hokkaido University)

[WP-31-8] Updated experiences of production and radiolabeling of At-211 for targeted alpha therapy in South Korea

Choong Mo Kang^1,2、Changkeun Im^1,2、Hwisoo Lim^1,2、Seyoung Oh¹、SangChul Mun¹、Kyo Chul Lee¹、Yong Jin Lee¹ (1.Division of Applied RI, Korea Institute of Radiological & Medical Sciences、2.Radiological and Medico-Oncological Sciences, University of Science and Technology)

Session information

Radiopharmacy1

Technology